Treace Medical Concepts Inc (TMCI)
7.94
-0.04
(-0.50%)
USD |
NASDAQ |
Nov 21, 16:00
7.95
+0.01
(+0.13%)
Pre-Market: 20:00
Treace Medical Concepts Profit Margin (Quarterly): -34.07% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -34.07% |
| June 30, 2024 | -47.70% |
| March 31, 2024 | -36.54% |
| December 31, 2023 | -10.10% |
| September 30, 2023 | -42.99% |
| June 30, 2023 | -29.25% |
| March 31, 2023 | -31.89% |
| December 31, 2022 | -8.86% |
| September 30, 2022 | -36.71% |
| June 30, 2022 | -57.51% |
| Date | Value |
|---|---|
| March 31, 2022 | -31.11% |
| December 31, 2021 | -19.79% |
| September 30, 2021 | -29.69% |
| June 30, 2021 | -24.61% |
| March 31, 2021 | -13.00% |
| December 31, 2020 | 10.65% |
| September 30, 2020 | -18.61% |
| June 30, 2020 | -25.49% |
| March 31, 2020 | -14.28% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-57.51%
Minimum
Jun 2022
10.65%
Maximum
Dec 2020
-26.40%
Average
-29.25%
Median
Jun 2023
Profit Margin (Quarterly) Benchmarks
| Stryker Corp | 15.18% |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | -18.58% |
| Xtant Medical Holdings Inc | -17.98% |
| Catheter Precision Inc | -4.29K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -49.68% |
| Return on Assets | -26.20% |
| Return on Invested Capital | -34.77% |
| Gross Profit Margin (Quarterly) | 80.14% |
| Operating Margin (Quarterly) | -33.57% |
| Return on Net Operating Assets | -49.26% |